Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy

Objectives: Diabetes mellitus (DM) is a significant risk factor for ischemic stroke and associated with platelet reactivity. We aim to evaluate the effect of DM on platelet function in acute ischemic stroke patients taking dual antiplatelet therapy (DAPT).Methods: We consecutively included patients...

Full description

Bibliographic Details
Main Authors:	Yinping Guo, Yi Zhang, Jing Zhao, Lingshan Wu, Zhiyuan Yu, Dan He, Hao Huang, Xiang Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Neurology
Subjects:	diabetes mellitus dual antiplatelet therapy (DAPT) ischemic stroke platelet function thromboelastography (TEG)
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.712024/full

Similar Items

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Triglyceride glucose index influences platelet reactivity in acute ischemic stroke patients
by: Yinping Guo, et al.
Published: (2021-10-01)

Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
by: Hiba Naveed, et al.
Published: (2023-11-01)

Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)

The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review
by: Joanna Sikora, et al.
Published: (2022-01-01)

Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes
by: Jan H. Cornel, et al.
Published: (2016-10-01)

Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review
by: Bernard P. L. Chan, et al.
Published: (2024-01-01)

Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
by: Christessa Emille Que Albay, et al.
Published: (2020-06-01)

Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis
by: Grigorios Tsigkas, et al.
Published: (2023-02-01)

Cilostazol-based dual antiplatelet treatment in ischemic stroke or transient ischemic attack patients with asymptomatic carotid artery disease: a propensity score matching analysis
by: Thon Thiraworawong, et al.
Published: (2024-02-01)

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
by: Zhaohan Xu, et al.
Published: (2022-02-01)

Site-Of-Care Viscoelastic Assay in Major Trauma Improves Outcomes and Is Cost Neutral Compared with Standard Coagulation Tests
by: Catriona Cochrane, et al.
Published: (2020-07-01)

Platelet antiaggregants in the treatment and prevention of ischemic stroke
by: Andrei Viktorovich Fonyakin
Published: (2013-12-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review
by: Adam Wiśniewski, et al.
Published: (2020-09-01)

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
by: Xiao‐Qiu Li, et al.
Published: (2022-07-01)

Antiplatelets in secondary stroke prevention
by: Olga eShulga, et al.
Published: (2011-07-01)

Circulating Microvesicles in Convalescent Ischemic Stroke Patients: A Contributor to High-On-Treatment Residual Platelet Reactivity?
by: Diana Schrick, et al.
Published: (2022-05-01)

Acute Ischemic Stroke With Mild Symptoms–To Thrombolyse or Not to Thrombolyse?
by: Julia Ferrari, et al.
Published: (2021-11-01)

Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2022-06-01)

Cost‐Effectiveness of Increased Use of Dual Antiplatelet Therapy After High‐Risk Transient Ischemic Attack or Minor Stroke
by: Paul M. Wechsler, et al.
Published: (2024-04-01)

Standard vs. Modified Antiplatelet Therapy Based on Thromboelastography With Platelet Mapping for Preventing Bleeding Events in Patients Undergoing Stent-Assisted Coil for a Ruptured Intracranial Aneurysm
by: Yuanshu Li, et al.
Published: (2021-01-01)

Factors Associated With Administration of Antiplatelet Therapy on The NIHSS Score in Acute Ischemic Stroke
by: Eddy Ratnaningsih Chrisstawati, et al.
Published: (2023-11-01)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
by: Chun-Jen Lin, et al.
Published: (2022-09-01)

Efficacy and safety of 3-month dual antiplatelet therapy in patients after mechanical thrombectomy for acute ischemic stroke: a retrospective study
by: Liang Li, et al.
Published: (2024-04-01)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
by: Shuqi Zhang, et al.
Published: (2022-05-01)

Antiplatelet Drugs and Its Gastrointestinal Side Effects among Ischemic Stroke Patients in Dr. Hasan Sadikin General Hospital 2011
by: Ananthakrishnan A/L Rajendram, et al.
Published: (2015-03-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease
by: Dong-Liang Fu, et al.
Published: (2017-01-01)

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
by: Liang Dong, et al.
Published: (2022-07-01)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
by: Marie Muthspiel, et al.
Published: (2022-11-01)

Dual antiplatelet therapy is associated with favorable outcome in acute minor stroke with an onset-to-door time beyond 24 h
by: Po-Lin Chen, et al.
Published: (2024-04-01)

Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram ® Platelet Mapping™
by: Kenneth N Hiller
Published: (2016-01-01)

Microplastic Effects on Thrombin–Fibrinogen Clotting Dynamics Measured via Turbidity and Thromboelastography
by: Daniela Q. Tran, et al.
Published: (2022-12-01)

Exploring microplastic impact on whole blood clotting dynamics utilizing thromboelastography
by: Alexei Christodoulides, et al.
Published: (2023-07-01)

The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study
by: Syed Nabeel Muzaffar, et al.
Published: (2022-02-01)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
by: Grigorios Tsigkas, et al.
Published: (2023-03-01)

Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack
by: A. V. Fonyakin, et al.
Published: (2021-10-01)

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
by: Ma Y, et al.
Published: (2018-05-01)

Prevalence and associated factors of premature discontinuation of antiplatelet therapy after ischemic stroke: a nationwide population-based study
by: Seung Jae Kim, et al.
Published: (2021-09-01)